Sleep Apnea Increases Risk for Cardiovascular Risk Factors and Events
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, July 19, 2024 -- Obstructive sleep apnea (OSA) is associated with an increased risk for cardiovascular disease (CVD) in adults, even those younger than 40 years, according to a study published online June 6 in the Journal of the American Heart Association.
Chance Strenth, Ph.D., from University of Texas Southwestern Medical Center Dallas, and colleagues assessed the prevalence of probable OSA and its relationship with cardiovascular risks and diseases. The analysis included data from 9,887 community-dwelling adults participating in the National Health and Nutrition Examination Survey (2013 to 2018).
The researchers found individuals with probable OSA had a significantly higher prevalence of health conditions, including hypertension (adjusted prevalence ratio [aPR], 1.19), diabetes (aPR, 1.17), metabolic syndrome (aPR, 1.14), heart attack (aPR, 1.63), stroke (aPR, 1.41), and any CVD event (aPR, 1.36) when adjusting for relevant factors. Young adults (ages 20 to 40 years) with probable OSA had higher prevalence rates of any CVD events (aPR, 3.44), hypertension (aPR, 1.45), metabolic syndrome (aPR, 1.25), and angina (aPR, 10.39).
"While cross-sectional, [the study] emphasizes that health care providers should recognize OSA as significantly associated with CVDs and its precursor risks in young adults, stressing proactive care and screening to reduce CVD risk in this population," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-20 01:15
Read more
- New Drug Regimen Extends Survival for Cervical Cancer Patients
- Lithium Aspartate Not Effective for Neurologic Long COVID Fatigue
- Half of Patients With Sepsis Die Within 2 Years, Hospital Study Finds
- American College of Gastroenterology, Oct. 25-30
- Orexo initiates new study of OX640 in participants with allergic rhiniti
- COVID Vaccine Mistrust Levels Aren't Budging, Study Finds
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions